J 2001

Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells

DVOŘÁKOVÁ, Dana, Pavel KREJČÍ, Jiří MAYER, Jiří FAJKUS, Aleš HAMPL et. al.

Basic information

Original name

Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells

Authors

DVOŘÁKOVÁ, Dana (203 Czech Republic), Pavel KREJČÍ (203 Czech Republic), Jiří MAYER (203 Czech Republic), Jiří FAJKUS (203 Czech Republic), Aleš HAMPL (203 Czech Republic) and Petr DVOŘÁK (203 Czech Republic, guarantor)

Edition

British Journal of Haematology, Oxford, Blackwell Science Ltd, 2001, 0007-1048

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.815

RIV identification code

RIV/00216224:14330/01:00004756

Organization unit

Faculty of Informatics

Keywords in English

fibroblast growth factor receptor 3; chronic myeloid leukaemia; stem cell transplantation; BCR/ABL; prognosis

Tags

BCR/ABL, chronic myeloid leukaemia, prognosis, stem cell transplantation

Tags

International impact, Reviewed
Změněno: 5/1/2007 15:39, prof. RNDr. Jiří Fajkus, CSc.

Abstract

V originále

Patients suffering from CML express high levels of FGFR3 mRNA in white blood cells (WBCs). After stem cell transplantation and reconstitution of haematopoiesis, the expression of FGFR3 decreased and was maintained at low levels that are typical of healthy individuals. FGFR3 expression became upregulated again in patients that had accelerated BCR/ABL rearrangement and underwent relapse of leukaemia.

Links

GA301/99/0045, research and development project
Name: Dynamika telomer u vybraných typů solidních maligních onemocnění
Investor: Czech Science Foundation, Telomere dynamics in selected types of solid malignant diseases
IBS5004010, research and development project
Name: Vývoj nových diagnostických technik pro onkologii
Investor: Academy of Sciences of the Czech Republic, Development of new diagnostic teniques for oncology
MSM 143100008, plan (intention)
Name: Genomy a jejich funkce
Investor: Ministry of Education, Youth and Sports of the CR, Genomes and their functions
Displayed: 9/11/2024 04:13